Comparison of Mortality Outcomes in Acute Myocardial Infarction Patients With or Without Standard Modifiable Cardiovascular Risk Factors

BACKGROUND: Acute myocardial infarction (AMI) cases have decreased in part due to the advent of targeted therapies for standard modifiable cardiovascular disease risk factors (SMuRF). Recent studies have reported that ST-elevation myocardial infarction (STEMI) patients without SMuRF (termed “SMuRF-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Sia, Ching-Hui, Ko, Junsuk, Zheng, Huili, Ho, Andrew Fu-Wah, Foo, David, Foo, Ling-Li, Lim, Patrick Zhan-Yun, Liew, Boon Wah, Chai, Ping, Yeo, Tiong-Cheng, Yip, James W. L., Chua, Terrance, Chan, Mark Yan-Yee, Tan, Jack Wei Chieh, Figtree, Gemma, Bulluck, Heerajnarain, Hausenloy, Derek J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047915/
https://www.ncbi.nlm.nih.gov/pubmed/35497977
http://dx.doi.org/10.3389/fcvm.2022.876465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047915/
https://www.ncbi.nlm.nih.gov/pubmed/35497977
http://dx.doi.org/10.3389/fcvm.2022.876465

Ejemplares similares